Data mining and network analysis of Xiyanping injection in the treatment of viral intestinal infection based on the real world

doi:10.19803/j.1672-8629.2022.02.01

Abstract

Abstract: Objective To analyze the way in which Xiyanping injection is used in the treatment of viral intestinal infections so as to guide clinical rational medication. Methods Based on the hospital information management system (HIS) database constructed by the Institute of Clinical Basic Medicine of Chinese Academy of Traditional Chinese Medicine, the clinical data on 1 814 patients with intestinal infections treated with Xiyanping injection in 29 hospitals between December 1, 2006 and June 30, 2016 was analyzed; and the patterns of combined medications were studied. The data was processed with the Tabu search algorithm. Results The most frequently used western medicine was oral rehydration salt, compound vitamin, cimetidine and antibiotics. The most frequently used traditional Chinese medicine was antipyretic, astringent and antipyretic antidote. Conclusion In the treatment of viral intestinal infections, Xiyanping injection is often combined with vitamins, oral rehydration salt or with antipyretic antidotes and astringents to combat viruses, cure diarrhea, adjust the gastrointestinal environment and provide symptomatic treatment.

Key words: real world, Xiyanping injection, viral intestinal infection, complex network

CLC Number:

R932R975

JI Hong, WANG Zhifei, XIE Yanming, LI Lixun, WEI Ruili, WANG Qi. Data mining and network analysis of Xiyanping injection in the treatment of viral intestinal infection based on the real world[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 117-120.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.2022.02.01

https://zgywjj.magtechjournal.com/EN/Y2022/V19/I2/117

References

[1] KANG P.Xi Yanping's therapeutic effect and safety analysis on rotav-irus enteritis in children[J]. China Modern Drug Application(中国现代药物应用), 2020, 14(2): 152-153.
[2] YUAN X.Analysis of pathogenic factors of 200 cases of infantile diarrhea and its clinical treatment significance[J]. Smart Healthcare(智慧健康), 2018, 16: 14.
[3] LI SD.Progress in the treatment of children’s diarrhea[J]. Forum on Primary Medicine(基层医学论坛), 2016, 20(6): 817-819.
[4] ZHANG JZ.Progress in drug treatment of viral enteritis in children[J]. Journal of Appropriate Clinical Medication(临床合理用药), 2019, 12(2): 2.
[5] WANG ZF, XIE YM.Xiyanping injection HIS clinical dose application analysis based on the real world[J]. Chinese Journal of Chinese Materia Medical(中国中药杂志), 2012, 37(18): 2727-2729.
[6] ZHOU W, LUO YC.Observation on the curative effect of Xiyanping in the treatment of 58 cases of infantile rotavirus diarrhea with myocardial damage[J]. Zhejiang Journal of Traditional Chinese Medicine(浙江中医杂志),2013, 48(8): 8.
[7] WANG SH.Clinical literature research on the treatment of enteritis by Gegen Qinlian Decoction based on main databases[D]. China Academy of Chinese Medical Sciences, 2020.
[8] CAI S, ZHU QX.Research progress in rotavirus infection[J]. Chinese Clinical Research(中国临床研究), 2019, 32(8): 1132-1134.
[9] LU YB.48 cases of infantile autumn diarrhea treated with montmor-illonite powder and shenlingbaizhu granule[J]. JCM(社区医学杂志), 2012, 10(2): 3.
[10] LIU Q.The clinical effect of moxibustion combined with montmorillonite powder and bifidobacterium triple viable bacteria powder in the treatment of rotavirus enteritis in children[J]. China Contemporary Medicine(中国当代医药), 2019, 26(2): 98-100.
[11] WANG LX, YANG W, XIE YM, et al.4023 cases of real-world
clinical application and safety analysis of Xiyanping injection patients[J]. Journal of Traditional Chinese Medicine(中医杂志), 2014, 55(7): 571-575.
[12] DU LJ, XIE YM, WANG ZF, et al.Analysis of the influence of Xiyanping injection on renal function in the real world based on propensity scoring method[J]. Beijing Traditional Chinese Medicine(北京中医药), 2016, 35(3):205-206.

[1]	XIE Ziyue, WANG Chengxiang, HU Yanpeng, LI Lei, CUI Herong. Clinical Medications and Safety Analysis of Traditional Chinese Medicine for Post-Infection Cough [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 507-512.
[2]	CHENG Yijing, LI Tao, LIU Junting, HUANG Guimin, ZHONG Xuli, LIN Aihua, PAN Shoudong, LI Long, BAI Dongsheng, ZHAN Xiaojun, LIU Zhenjiang, REN Wei, NIE Xiaolu, TAI Jun. Safety evaluation of haemocoagulase agkistrodon for injection in children based on real world data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 787-790.
[3]	PAN Zhiyu, ZHU Jian, YU Yanan, LIU Jun, JIANG Yanhua, QIAN Zhenzhen, WU Guang, WANG Zhong, WU Hongli, JING Zhiwei. A real-world safety study of 3 010 cases of Qizhitongluo capsule [J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 660-665.
[4]	WANG Shubo, JIAO Tingting, DONG Hongliang, WANG Bailing, LI Hui. A model for prediction of risk factors of acute kidney injury induced by voriconazole for injection based on real-world data [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 567-571.
[5]	SUN Xuelin, DU Jiao, TAN Qin, ZHANG Yatong, HU Xin. Real-world data on medications with vitamin injections [J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1125-1129.
[6]	SHI Bowen, LI Lixun, XIE Yanming, WANG Zhifei, WANG Qi. Clinical characteristics of Xiyanping injection in 3846 patients with bacterial intestinal infection in the real world [J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1017-1021.
[7]	DU Ying, ZHAO Xiaoxiao, XIE Yanming, YU Xiaokang. Effects of elemene emulsion injection on liver function injury in the real world based on propensity scores [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 191-195.
[8]	WANG Jiaxi, GUO Daihong, ZHANG Bo, Li Boyan, GUO Haili. Automatic monitoring and risk factors of acute kidney injury in 116097 dosing cases of flurbiprofen axetil [J]. Chinese Journal of Pharmacovigilance, 2023, 20(2): 201-205.
[9]	HUANG Yanli, XIE Yanming, WANG Lianxin, SUN Linxi, LIU Huan, ZHUANG Yunni. Clinical applications of Ciwujia injection in elderly patients in the real world [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 935-939.
[10]	ZHAO Xiaoxiao, XIE Yanming, WANG Lianxin. Clinical applications of elemene emulsion injection in the treatment of lung cancer in the real world based on association rules [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 940-946.
[11]	TAN Chang, ZHAO Xiaoxiao, ZHI Yingjie, WANG Lianxin, XIE Yanming. Clinical characteristics and combined medications of elemene emulsion injection in the treatment of brain tumors [J]. Chinese Journal of Pharmacovigilance, 2022, 19(9): 947-953.
[12]	DU Ying, WANG Zhifei, XIE Yanming, WANG Lianxin, LI Lixun, LIU Zhishuai. Complex network analysis of combined regimens of Xiyanping injection in the treatment of hand-foot-mouth disease [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 839-844.
[13]	ZHANG Hongwei, LI Yuanyuan, XIE Yanming, MA Xiaochang, WANG Lianxin, WEI Ruili, SUN Linxi, XU Hongyan, ZHUANG Yan. The drug combination of Danshen Ligustrazine injection in the real world [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 851-856.
[14]	ZHANG Lei, LI Yuanyuan, XIE Yanming, WANG Lianxin, YANG Xiaochen. The medication of Breviscapine injection in the treatment of angina pectoris in the real world [J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 857-861.
[15]	YAO Yu, LI Yuanyuan, WEI Xu, XIE Yanming, WANG Zhifei, GAO Minghui. Influencing factors of suspected allergic reactions related to cervus and cucumis polypeptide for injection in the real world [J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 740-743.